IRIS
IPPOLITO, EDY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.865
NA - Nord America 1.708
EU - Europa 980
SA - Sud America 196
AF - Africa 41
OC - Oceania 6
Totale 9.796
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.788
US - Stati Uniti d'America 1.636
CN - Cina 609
IT - Italia 469
HK - Hong Kong 207
BR - Brasile 131
FR - Francia 110
DE - Germania 100
VN - Vietnam 85
GB - Regno Unito 81
NL - Olanda 60
IN - India 40
EE - Estonia 33
FI - Finlandia 31
CA - Canada 30
AR - Argentina 26
MX - Messico 26
BD - Bangladesh 21
ID - Indonesia 21
TR - Turchia 17
IQ - Iraq 15
ZA - Sudafrica 15
ES - Italia 13
UA - Ucraina 13
CZ - Repubblica Ceca 10
EC - Ecuador 10
AT - Austria 9
JP - Giappone 9
PL - Polonia 8
RO - Romania 8
RU - Federazione Russa 8
SE - Svezia 8
CL - Cile 7
PK - Pakistan 7
SA - Arabia Saudita 7
AU - Australia 5
CO - Colombia 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 4
TW - Taiwan 4
CR - Costa Rica 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CM - Camerun 2
EG - Egitto 2
GT - Guatemala 2
IE - Irlanda 2
KZ - Kazakistan 2
LB - Libano 2
LY - Libia 2
MA - Marocco 2
NI - Nicaragua 2
PS - Palestinian Territory 2
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GF - Guiana Francese 1
GN - Guinea 1
GP - Guadalupe 1
HT - Haiti 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LV - Lettonia 1
ME - Montenegro 1
MG - Madagascar 1
ML - Mali 1
MR - Mauritania 1
MW - Malawi 1
NA - Namibia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 9.793
Salva come PNG Salva come JPEG
Città #
San Jose 639
Singapore 519
Rome 354
Ashburn 270
Hong Kong 203
Beijing 192
Dallas 190
Hefei 182
Lauterbourg 90
Munich 62
Boardman 61
Shanghai 58
London 55
New York 49
Amsterdam 46
Santa Clara 34
Los Angeles 31
Ho Chi Minh City 29
Council Bluffs 27
Hanoi 22
São Paulo 19
Mexico City 18
Helsinki 17
Milan 16
Brooklyn 15
Toronto 14
Turku 14
San Francisco 12
Washington 12
Frankfurt am Main 11
Orem 10
Chennai 9
Brno 8
Seattle 8
West Jordan 8
Ankara 7
Boston 7
Chicago 7
Atlanta 6
Baghdad 6
Johannesburg 6
Pune 6
Redmond 6
Sona 6
Tokyo 6
Charlotte 5
Guangzhou 5
Haiphong 5
Jakarta 5
Lima 5
Mumbai 5
New Delhi 5
Nuremberg 5
Rocca di Papa 5
Stockholm 5
Warsaw 5
Buffalo 4
Denver 4
Dhaka 4
Guayaquil 4
Hải Dương 4
Lahore 4
Philadelphia 4
Quito 4
Rio de Janeiro 4
Santiago 4
Vicenza 4
Barcelona 3
Bologna 3
Buenos Aires 3
Capaccio 3
Hangzhou 3
Manchester 3
Minneapolis 3
Montesilvano Marina 3
Naples 3
Osimo 3
Palermo 3
Phoenix 3
San José 3
Sumaré 3
Tashkent 3
Temecula 3
Vienna 3
Wuhan 3
Ananindeua 2
Asunción 2
Bangalore 2
Banqiao 2
Belo Horizonte 2
Boca Raton 2
Bucharest 2
Cagliari 2
Cardiff 2
Central 2
Cincinnati 2
City of London 2
Cleveland 2
Cotia 2
General Roca 2
Totale 3.550
Salva come PNG Salva come JPEG
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 338
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 276
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 233
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I–II study (ADA-RT-1) 230
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 228
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 227
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 225
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 225
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 219
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 218
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 218
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer 218
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 216
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 216
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 211
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 206
Preventing Cardiotoxicity in Personalized Breast Irradiation 201
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study 199
Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform 198
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 196
Lymph nodal radiotherapy in breast cancer: what are the unresolved issues? 193
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 156
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 149
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 145
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 140
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 135
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 132
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 132
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 131
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 128
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 127
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 127
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 123
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 120
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 119
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 118
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 117
Daily on-line set-up correction in 3D-conformal radiotherapy: Is it feasible? 111
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 110
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 104
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 102
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 100
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study 94
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 86
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 85
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 83
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 82
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 80
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1) 66
Precision radiotherapy by SPECT lung functional imaging in NSCLC 65
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 59
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 57
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 55
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 50
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 49
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 49
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 48
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 46
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 46
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 43
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach 43
Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups 43
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 41
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/ RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups 40
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 40
SBRT: A viable option for treating adrenal gland metastases 40
IGRT in rectal cancer 39
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 39
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 39
PV-0276 Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC. 39
Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6 38
Occult mediastinal node involvement in non-small cell lung cancer after negative uptake on PET/CT: Ripples through staging and therapy. Case report and critical review 38
Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment 38
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 37
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: A case series 37
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. 37
PO-0672 Ten years experience of breast reconstruction after mastectomy in previously irradiated patients 37
Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature 37
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 37
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion preliminary report on toxicity 36
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups 36
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study † 36
Radiotherapy in breast cancer with voluntary deep- inspiration breath-hold using BrainLab Exactrac 36
External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study 35
Predictive factors of late-onset rectal mucosal changes after radiotherapy of prostate cancer 35
Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group 35
Stereotactic body radiation therapy for early stage NSCLC: clinical outcomes 34
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 33
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 33
Postoperative Intensity Modulated Radiation Therapy in High Risk Prostate Cancer: A Dosimetric Comparison 31
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 30
Brain MRI and regional vulnerabilities to radiation necrosis: investigating the impact of stereotactic radiotherapy in brain metastases treatment 30
Patterns of practice for breast cancer post-operative radiation therapy in Italy according to the ESTRO-ACROP consensus and AIRO position paper: a national survey on the behalf of the Italian association of radiotherapy and clinical oncology (AIRO) 29
The role of mammography after breast-conserving surgery and adjuvant chemotherapy 29
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 29
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: A phase I study 28
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 27
Durvalumab in Small-Cell Lung Cancer 25
Life after oncoplastic surgery (IRONY) trial: Preliminary results 24
The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria 21
Totale 9.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 2 4 3 2 1 3 10 3 0 56
2022/202341 0 1 0 2 1 1 4 13 3 0 12 4
2023/2024231 8 19 15 11 17 82 13 11 3 17 10 25
2024/20256.064 41 20 121 63 38 103 78 27 227 384 2.316 2.646
2025/20263.479 286 176 234 316 171 226 1.076 244 280 373 97 0
Totale 9.899